V
Veritable Portfolio holdings
AUM
$6.17B
This Quarter Return
+7.64%
1 Year Return
+16.27%
3 Year Return
+46.92%
5 Year Return
+59.95%
10 Year Return
+156.88%
AUM
$5.88B
AUM Growth
+$5.88B
(+9.7%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
56.76%
Holding
853
New
72
Increased
332
Reduced
327
Closed
18
Top Buys
| 1 |
Comcast
CMCSA
|
$54.9M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$32.4M |
| 3 |
Nuveen Quality Municipal Income Fund
NAD
|
$20.9M |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
$17.2M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$7.77M |
Top Sells
| 1 |
iShares Russell 1000 ETF
IWB
|
$16.8M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$16.1M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
$11.1M |
| 4 |
Mastercard
MA
|
$3.63M |
| 5 |
Chubb
CB
|
$3.32M |
Sector Composition
| 1 | Technology | 5.43% |
| 2 | Financials | 4.44% |
| 3 | Communication Services | 3.68% |
| 4 | Healthcare | 3.11% |
| 5 | Consumer Discretionary | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-3,543
| Closed | -$203K |
|
852
Albemarle
ALB
$9.43B
| – | – |
-1,808
| Closed | -$267K |
|
|
BMY.RT
853
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-12,428
| Closed | -$9K |
|